Moreover, anti-B-ALL immunity in Tyro3-/- mice was less dependent on CD8+ DCs compared to Mertk-/- mice, indicating a different underlying immune mechanism. This evidence concerns the gene TYRO3 and precursor B-cell acute lymphoblastic leukemia.